Pharmaceutical Technology

SEPTEMBER 26, 2022

Two single-country trials and 44 multinational investigations with a site in Ukraine have started over the past six months, according to Global Data, with research covering infectious diseases, cardiology, schizophrenia, and gastrointestinal therapies.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Regulation 130

Delveinsight

DECEMBER 29, 2020

Food and Drug Administration has given a green signal to the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia. . Welcome the First Generic of Drug for Severe Hypoglycemia.

Trials 52

Trials Drugs Hormones Radiology 52

XTalks

FEBRUARY 8, 2024

According to AstraZeneca, the drug had strong demand across all of its approved indications and was further supported by recent guideline updates from cardiology societies. for a 2-pen package (0.6 & 1.2 for a 3-pen package (1.8 This performance exceeded Wall Street’s expectations by 20 percent. mg doses), or $815.27

Sales 52

Sales Insulin FDA Approval Drugs 52

XTalks

AUGUST 2, 2023

2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19. a month for either 150 mg or 300 mg dose strength packages, and $3,462.13 for the 75 mg dose strength package in January 2023, according to the manufacturer. for a 2-pen package (0.6 for the 3-pen package (1.8

Sales 98

Sales Manufacturing FDA Approval Life Science 98